Doç. Dr. Süleyman KARAKÖSE

1. Impact of crush syndrome severity on clinical outcomes after the earthquakes in southeastern Türkiye

Turgutalp K., Ozturk S., Koc N. S., Dolarslan M. E., KOÇYİĞİT İ., TURGUT D., et al.

BMC Nephrology , cilt.27, sa.1, 2026 (SCI-Expanded, Scopus)

2. Early laboratory trajectories and short-term tolerability after finerenone initiationin diabetic kidney disease: the multicenter FINE-TURK study

Yadigar S., Akgür S., Arslan F., Sezen M., Özcan B., Ayaz E. Y., et al.

BMC Nephrology , cilt.27, sa.1, 2026 (SCI-Expanded, Scopus)

3. Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort

ÖZDEDE M., Yadigar S., GÜVEN A. T., Akgür S., Arslan F., Sezen M., et al.

Clinical Kidney Journal , cilt.19, sa.8, 2026 (SCI-Expanded, Scopus)

4. Hyperkalemia Risk After Finerenone Initiation in Diabetic Kidney Disease with Elevated Baseline Potassium: A Multicenter Cohort Study

GÜVEN A. T., Yadigar S., ÖZDEDE M., Akgür S., Arslan F., Sezen M., et al.

Journal of Clinical Medicine , cilt.15, sa.15, 2026 (SCI-Expanded, Scopus)

5. Finerenone Use in Heart Failure Patients with Type 2 Diabetes and Kidney Disease: An Analysis of the FINE-TURK Registry

Yadigar S., Akgür S., Güvenç T. S., Sezen M., Özcan B., Yıldırım Ayaz E., et al.

Cardiovascular Drugs and Therapy , 2026 (SCI-Expanded, Scopus)

6. The effect of sodium-glucose cotransporter-2 inhibitors on haemoglobin and haematocrit in diabetic kidney disease

KARAKÖSE S., Doğan B., Ergül F., GÜNEY İ.

Revista da Associacao Medica Brasileira , cilt.72, sa.3, 2026 (SCI-Expanded, Scopus)

7. The Relationship Between Mucociliary Clearance Time and Peritonitis Frequency in Patients Receiving Peritoneal Dialysis

Doğan B., Ergül F., Basut R., KARAKÖSE S., YÜCEL A., Dağ M., et al.

Turkish Journal of Nephrology , cilt.35, sa.1, ss.67-71, 2026 (ESCI, Scopus, TRDizin)

8. Pre-earthquake kidney function is a predictor of outcomes in earthquake-related crush syndrome

DANİŞ R., ÖZTÜRK S., KOÇYİĞİT İ., Kılıç J., Civan M., ŞAHUTOĞLU T., et al.

BMC Nephrology , cilt.26, sa.1, 2025 (SCI-Expanded, Scopus)

9. The Effect of Arteriovenous Fistula Creation on GFR Decline

Doğan B., Ergül F., Dağ M., KARAKÖSE S., GÜNEY İ.

Therapeutic Apheresis and Dialysis , cilt.29, sa.5, ss.747-751, 2025 (SCI-Expanded, Scopus)

10. Case Report: Do We Underestimate the E148Q Mutation? Uncharacterized Variant

Doğan B., Ergül F., Dağ M., KARAKÖSE S., GÜNEY İ., ERKUŞ E., et al.

International Journal of Rheumatic Diseases , cilt.28, sa.5, 2025 (SCI-Expanded, Scopus)

11. Assessing ciliary function in polycystic kidney disease: beyond the kidney

Doğan B., Ergül F., Dağ M., KARAKÖSE S., Özdemir L. E., YÜCEL A., et al.

Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine , cilt.80, sa.6, ss.186-192, 2025 (SCI-Expanded, Scopus)

12. A rare cause of acute kidney injury due to recurrent rhabdomyolysis: Carnitine palmitoyltransferase 2 deficiency

Ozkan Kurtgoz P., KARAKÖSE S., GÜNEY İ.

Hemodialysis International , cilt.29, sa.1, ss.130-133, 2025 (SCI-Expanded, Scopus)

13. Epidemiological analysis of the victıms wıth crush syndrome in earthquakes of southeastern Turkey

Ozturk I., Gungor O., Ozturk S., Olmaz R., Keskin A. J. G., KOÇYİĞİT İ., et al.

Journal of Nephrology , cilt.37, sa.9, ss.2589-2599, 2024 (SCI-Expanded, Scopus)

14. Patients with crush syndrome and kidney disease: lessons learned from the earthquake in Kahramanmaraş, Türkiye

Ozturk S., TUĞLULAR Z. S., Olmaz R., KOÇYİĞİT İ., Kibar M. U., Turgutalp K., et al.

Kidney International , cilt.106, sa.5, ss.771-776, 2024 (SCI-Expanded, Scopus)

15. The comparison of paricalcitol and calcitriol effects on pulse wave velocity, osteocalcin, and fetuin-A in chronic hemodialysis patients

KARAKÖSE S., Bal Z., Sezer S.

Seminars in Dialysis , cilt.37, sa.2, ss.131-137, 2024 (SCI-Expanded, Scopus)

16. The impact of COVID-19 pandemic on anxiety levels among patients who have to go to the hospital due to chronic illnesses: A prospective study

Ozkan Kurtgoz P., Sackan F., Oner I., Bilgin O., Ozdemir D., KARAKÖSE S., et al.

Therapeutic Apheresis and Dialysis , cilt.27, sa.4, ss.711-719, 2023 (SCI-Expanded, Scopus)

17. Evaluation of sirtuin 1 (SIRT1) levels in autosomal dominant polycystic kidney disease

Ozkan Kurtgoz P., KARAKÖSE S., Cetinkaya C. D., ERKUŞ E., GÜNEY İ.

International Urology and Nephrology , cilt.54, sa.1, ss.131-135, 2022 (SCI-Expanded, Scopus)

18. Pregnancy and its outcomes in hemodialysis patients in Turkey

Dheir H., Güngör Ö., Ulu S., GÖK OĞUZ E., EREN N., Altunören O., et al.

Turkish Journal of Medical Sciences , cilt.52, sa.2, ss.354-360, 2022 (SCI-Expanded, Scopus, TRDizin)

19. The relationship of soluble klotho level with uremic cardiomyopathy and ecocardiographic parameters in hemodialysis patients

ERKUŞ E., BÜYÜKTERZİ Z., KARAKÖSE S., Kurku H., Kurtgoz P. O., Topal M., et al.

Seminars in Dialysis , cilt.34, sa.2, ss.157-162, 2021 (SCI-Expanded, Scopus)

20. THE EFFECT OF ARTERIAL STIFFNESS ON DISEASE PROGRESSION AND MORTALITY IN CHRONIC KIDNEY PATIENTS

ERKUŞ E., KARAKÖSE S., Kurtgöz P. Ö., Gençer V., GÜNEY İ.

Istanbul Tip Fakultesi Dergisi , cilt.84, sa.2, ss.214-220, 2021 (ESCI, Scopus, TRDizin)

21. Is There a Role of ADAMTS-1 in Cyst Development in Autosomal Dominant Polycystic Kidney Disease?

KARAKÖSE S., Kurtgöz P. Ö., Deniz Ç. D., ERKUŞ E., GÜNEY İ.

Turkish Journal of Nephrology , cilt.30, sa.1, ss.25-29, 2021 (ESCI, Scopus, TRDizin)

22. Thyroid disorders prevalence in a cohort of kidney transplant recipients

KARAKÖSE S., Cordan I., Gonulalan G., Karakose M., Kurtgoz P., Baloglu I., et al.

Acta Endocrinologica , cilt.16, sa.3, ss.324-328, 2020 (SCI-Expanded, Scopus)

Doç. Dr. Süleyman KARAKÖSE

Yayınlar & Eserler